Progress in Cardiovascular Diseases

Papers
(The H4-Index of Progress in Cardiovascular Diseases is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
CTA in roadmapping post-CABG evaluation470
List of recent issues276
Table of contents153
Updates in fluorodeoxyglucose positron emission tomography (18FDG-PET) in the diagnosis and management of cardiac sarcoidosis108
COVID-19 and coronary atherosclerosis: Unmasking and accelerating?106
Emerging tracers for cardiac imaging: Innovations and clinical implications93
Physical activity, fitness, and longevity92
Use of mechanical circulatory support in high-risk percutaneous coronary interventions91
Cover 2 (Masthead)73
Table of contents63
Cover 2 (Masthead)63
Cover 2 (Masthead)60
List of recent issues58
Table of contents53
Cover 2 (Masthead)52
Multimodality imaging of hypertrophic cardiomyopathy48
Estrogen and cardiovascular disease43
Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?43
Handgrip strength asymmetry increases risk of all-cause and cardiovascular mortality: A dose-response analysis across 28 countries42
Updates on obesity and the obesity paradox in cardiovascular diseases42
Evidence to support health system prioritization of health behaviors in the COVID-19 era40
List of recent issues37
Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress testing37
Timing of transcatheter aortic valve replacement after balloon aortic valvuloplasty: Insights from a multicenter real-world cohort37
Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID – Best practice approaches37
Editorial Board37
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy37
Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio35
List of recent issues35
Cover 2 (Masthead)34
Transthyretin amyloid cardiomyopathy: Evolving therapies, expanding hope33
A meta-analysis of direct oral anticoagulants vs warfarin for left ventricular thrombus33
The weekly mortality for ischemic heart disease in the US still peaks on mondays32
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis32
Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a “cholesterol paradox?”32
1.3072249889374